Boehringer Ingelheim

Encephalomyelitis-Rhinopneumonitis-Influenza-West Nile Virus Vaccine,

Eastern & Western & Venezuelan, Killed Virus

Tetanus Toxoid

Indications: For vaccination of healthy horses 4 months of age or older as an aid in the prevention of disease caused by Eastern, Western, and Venezuelan Encephalomyelitis, and tetanus; as an aid in the prevention of viremia and mortality, and an aid in the reduction of severity of clinical disease caused by West Nile Virus; as an aid in the reduction of respiratory disease caused by Equine Herpesvirus types 1 and 4 (EHV-1 and EHV-4), and Equine Influenza virus types A2 North American and A2 Eurasian. The duration of immunity against Equine Influenza is at least 6 months, and against West Nile Virus is at least 12 months.

Administration and Dosage: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure

with a single 1 mL intramuscular dose.

Precautions: Store at 35-45°F (2-7°C. Protect from freezing. Do not vaccinate within 21 days before slaughter. Use entire contents when first opened. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.

This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal, healthy, immunocompetent animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies, or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.

Preservatives: Gentamicin and Amphotericin B.

For Veterinary Use Only

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506

U.S. Veterinary License No. 124

NAC No.: 10282690